The Nitric Oxide Pathway in Pulmonary Arterial Hypertension: Pathomechanism, Biomarkers and Drug TargetsZsófia Lázár(Semmelweis University), András Bikov(University of Manchester)Current Medicinal ChemistryMay 22, 202010.2174/0929867327666200522215047Cited by 46SaveCiteExport RISWatch citationsRelated PapersObstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia|Biomedicines|2022|71